Sanofi

Sanofi a healthcare company engages in the research development manufacture and marketing of therapeutic solutions in the United States Europe and internationally. It operates through Pharmaceuticals Vaccines and Consumer Healthcare segments. The company provides specialty care such as dupixent neurology and immunology rare diseases oncology and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition it offers poliomyelitis pertussis and hib pediatric vaccines; influenza booster meningitis and travel and endemic vaccines which includes hepatitis A typhoid cholera yellow fever and rabies vaccines. The company also provides cough cold and flu allergy and pain care products as well as physical mental and digestive wellness products; and offers body lotions anti-itch products moisturizing and soothing lotions body and foot creams and eczema powders. Further it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design develop and commercialize antibody-drug conjugates for cancer. Additionally the company has a collaboration agreement with IGM Biosciences Inc. to develop manufacture and commercialize IgM antibody; Skyhawk Therapeutics Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris France.